Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

114.51

-0.36 (0.31%)

as of Jun 10, 2026, 8:00:00 pm Market Open.

214 watching

Investor Insights

Jun 9, 2026, 12:00 am

This summary was created by AI, based on 32 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) continues to evoke mixed opinions from experts, with many emphasizing its valuable proprietary data, especially for legal and accounting sectors. Some analysts recognize its potential to leverage AI technologies to enhance efficiency and product offerings. However, concerns around valuation persist, particularly with the stock's historical high PE ratios and recent downward trends. While there are varying perspectives on how AI may disrupt its core business, some analysts see TRI's unique data moat as a strong competitive advantage that may help it maintain resilience. Overall, while there are advocates for its long-term potential, there are also cautionary notes regarding its current market assessment and future revenue impacts from technological advancements.

Consensus

Hold

Valuation

Fair Value

Similar

Bloomberg, BDN

TOP PICK

(A Top Pick Aug 14/08. Down 4.25%.) Very solid/diversified underpinnings in the “have to have” information markets. Includes financials, legal and scientific. On the verge of having increases in profitability and looking for earnings of $2.50 in the next year. Cash flow could be $3.75-$4 a share. Developing “next generation” terminals.

WATCH

Good stable company. Global leader. Involves selling high-end data devices into law firms, Wall Street firms, etc. which is why the stock has not done a lot in the last year. European listing is being closed so a lot of Europeans will sell in the next month or two, which will be a buying opportunity.

COMMENT

Announced they will consolidate shares trading in London into Canada and this brings more liquidity to the Canadian marketplace. Doing interesting things in their communication business and are taking on the Bloomberg quite aggressively. Will be rolling out some products later in the year. Thinks he could do better in a recovery story with something that is a little more aggressive but if you are looking for a safe blue-chip name, this would qualify.

TOP PICK

Stock price dropped because of concerns of the financial industry. Market doesn't count on them being so well positioned in the legal and scientific areas. With the merger with Reuters, expects they will come out with some formidable competitor products next year.

TOP PICK

Market is underestimating the synergies, which are ahead of schedule. Reuters is coming out with a new generation of products. Expect employment figures will start increasing in the financial sector.

TOP PICK

Strong cash flow generator. Offers some of the best dividend growth potential as we get out to 2010-2011. Financial services sector is going to stabilize.

TOP PICK

Market thought they would be hurt by the slowdown in the financial services. Hasn't been a plus for them but the medical and legal divisions have continued to grow. Financial products have become more sophisticated. Cash flows from all the synergies on the merger are starting to show up but won't have their full impact until late 2010, early 2011.

TOP PICK

Reuters people in England have continued to sell the stock and that has been a real drag. Earnings and dividends are okay. He considers this a multinational stock and the world needs the kind of information systems they have. 3.7% yield.

PAST TOP PICK

(A Top Pick May 20/08. Down 4.51%.) It provides information on financials, legal, accounting and medical. Anticipates growth in earnings because of the cost reductions following the merger.

PAST TOP PICK

(A Top Pick May 29/08. Down 7.9%.) Will have some good surprises in the next year. Still a Buy.

COMMENT

Likes the business model. Global diversified business covering financial services, legal, tax, accounting and scientific/healthcare businesses. 4% dividend yield. Good cash position. Dual listed corporation in London and Toronto and London shares trade at a 10% discount so he would buy it in London.

COMMENT

Several factors on whether you buy Canadian (TRI-T) or US ADR (TRIN-Q). 3.7% yield Canadian but 4.2% in the US. If you have a taxable account you are probably better off buying Canadian.

PAST TOP PICK

(A Top Pick May 8/08. Down 0.71%.) Have come through the environment and are meeting all their targets on cost cutting and synergies. Concerned on losses because of the financial sector.

TOP PICK

(A Top Pick March 2/09.) 4.98% Bond due 2015 and yielding about 5%. Still doing very well. Very solid company.

PAST TOP PICK

(Top Pick Apr 15/08, Down 8.13%) They are strong in legal and scientific and other fields, which benefit them when times are bad. The integration with Reuters went well for them.

Showing 301 to 315 of 710 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)